Danaher (DHR)
(Delayed Data from NYSE)
$252.14 USD
+5.91 (2.40%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $252.23 +0.09 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Danaher Corporation [DHR]
Reports for Purchase
Showing records 201 - 220 ( 503 total )
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
1Q Pre-Announcement Indicates COVID Vaccine Acceleration
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Bioproduction: Sartorius Guide - Powerful COVID-19 Acceleration
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Life Sciences Tools: Declining COVID Test Volumes Shouldn''t Be a Surprise: Our View of the "Big Three"
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Life Science Tools: Hard and Soft Landings for COVID-19 Diagnostics and Vaccines
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department